Endpoints News 13 janv. 2026 Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News 12 janv. 2026 Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s
FierceBiotech 9 déc. 2025 Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Endpoints News 8 déc. 2025 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive 8 déc. 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 26 nov. 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3